Home > Press > Nanoparticle Delivers Antisense Agent to Tumors, Boosts Drug Effect in Resistant Tumors
![]() |
Abstract:
A multifunctional drug delivery system consisting of a lipid-based nanoparticle, a standard anticancer drug, and a short nucleic acid designed to augment the activity of that drug has demonstrated the ability to treat drug-resistant tumor cells. This work, published in the journal Clinical Cancer Research, suggests a novel approach to treating drug-resistant tumors, the leading cause of cancer deaths.
Tamara Minko, Ph.D., of Rutgers University, led the team of investigators that developed this novel nanotherapeutic system for treating cancer. She and her colleagues set out to target a signaling pathway that causes tumors to trigger new blood vessel growth and to develop resistance to many anticancer drugs. To shut down this pathway, the investigators developed an antisense oligonucleotide that would bind to and inactivate messenger RNA coding for a protein known as hypoxia-inducible factor-1α, which, when present, activates the targeted pathway.
To deliver this antisense agent to tumor cells, the investigators created a lipid-based nanoparticle, or liposome, that would stably incorporate both the antisense agent and the anticancer drug doxorubicin. The investigators also created two additional liposomes as controls, each of which was loaded with only one of the two therapeutic agents. Tests with both isolated tumor cells and with animals bearing human tumors showed that administration of the multifunctional nanoparticle was more effective at killing tumor cells than was coadministration of the two single-component liposomes. At the same time, the multifunctional liposome produced fewer side effects than did the combination of the two single-component liposomes. The investigators hypothesized that cells may have a limited ability to take up liposomes, so including both drugs in a single liposome would increase cellular uptake of the active ingredients relative to when these agents are delivered using two separate liposomes.
####
About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580
Copyright © National Cancer Institute
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
News and information
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Nanomedicine
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
Discoveries
Efficient and stable hybrid perovskite-organic light-emitting diodes with external quantum efficiency exceeding 40 per cent July 5th, 2024
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
Announcements
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |